News & Updates

The risk of major ischaemic and haemorrhagic events in patients with a history of cancer and cryptogenic stroke appears to be similar between those on apixaban and those on aspirin, according to a post hoc analysis of the ARCADIA* trial.

Regular consumption of olive oil may provide protective benefits against cancer, cardiovascular, and all-cause mortality, independent of overall diet quality, suggests a study.

A study conducted at the Cancer Genetics Clinic of the National University Cancer Institute, Singapore underlines the use of germline genetic testing in guiding therapeutic decisions in individuals with advanced cancers.

In patients with HRD+ advanced epithelial OC harbouring BRCA wild-type tumours, integrating durvalumab induction and durvalumab plus olaparib maintenance into 1L bevacizumab-containing chemotherapy significantly extends PFS and PFS2, suggest updated results from the DUO-O trial.

Adding olanzapine to prophylactic antiemetic medications appeared to substantially improve nausea and vomiting control among patients receiving moderately emetogenic chemotherapy (MEC) regimens in a phase III randomized clinical trial.

Liver transplantation (LT) in combination with chemotherapy, as opposed to chemotherapy alone, can provide a meaningful improvement in survival among patients with unresectable colorectal liver metastases, suggest the results of the TRANSMET trial presented at ESMO GI 2024.